LEGN
Price:
$19.3502
Market Cap:
$3.58B
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. ...[Read more]
Industry
Biotechnology
IPO Date
2020-06-05
Stock Exchange
NASDAQ
Ticker
LEGN
According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current ROE is -24.91%. This represents a change of 303.18% compared to the average of -6.18% of the last 4 quarters.
The mean historical ROE of Legend Biotech Corporation over the last ten years is -13.09%. The current -24.91% ROE has changed 90.36% with respect to the historical average. Over the past ten years (40 quarters), LEGN's ROE was at its highest in in the March 2020 quarter at 278.50%. The ROE was at its lowest in in the March 2019 quarter at -143.72%.
Average
-13.09%
Median
-32.19%
Minimum
-59.97%
Maximum
82.68%
Discovering the peaks and valleys of Legend Biotech Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.09%
Maximum Annual ROE = 82.68%
Minimum Annual Increase = -356.87%
Minimum Annual ROE = -59.97%
| Year | ROE | Change |
|---|---|---|
| 2025 | -29.62% | 74.09% |
| 2024 | -17.01% | -58.92% |
| 2023 | -41.41% | -30.94% |
| 2022 | -59.97% | 13.81% |
| 2021 | -52.69% | 18.24% |
| 2020 | -44.56% | -153.89% |
| 2019 | 82.68% | -356.87% |
| 2018 | -32.19% | -141.82% |
The current ROE of Legend Biotech Corporation (LEGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-29.35%
5-year avg
-40.14%
10-year avg
-13.09%
Legend Biotech Corporation’s ROE is greater than Disc Medicine, Inc. (-37.17%), greater than Zai Lab Limited (-24.29%), greater than Ascentage Pharma Group International (-123.61%), greater than Tarsus Pharmaceuticals, Inc. (-14.19%), greater than Adaptive Biotechnologies Corporation (-32.64%), greater than Scholar Rock Holding Corporation (-163.52%), greater than Celcuity Inc. (-244.61%), greater than CG Oncology Inc. (-23.33%), greater than Xenon Pharmaceuticals Inc. (-49.23%), greater than IDEAYA Biosciences, Inc. (-16.47%),
| Company | ROE | Market cap |
|---|---|---|
| -37.17% | $2.97B | |
| -24.29% | $2.06B | |
| -123.61% | $1.56B | |
| -14.19% | $2.61B | |
| -32.64% | $3.98B | |
| -163.52% | $5.71B | |
| -244.61% | $4.52B | |
| -23.33% | $6.38B | |
| -49.23% | $6.23B | |
| -16.47% | $3.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Legend Biotech Corporation's ROE?
How is the ROE calculated for Legend Biotech Corporation (LEGN)?
What is the highest ROE for Legend Biotech Corporation (LEGN)?
What is the 3-year average ROE for Legend Biotech Corporation (LEGN)?
What is the 5-year average ROE for Legend Biotech Corporation (LEGN)?
How does the current ROE for Legend Biotech Corporation (LEGN) compare to its historical average?